Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
17.16
-14.07
-81.99%
Share Warrants & Outstandings
Total Reserve
68.71
53.75
14.96
27.83%
Shareholder's Funds
71.80
78.19
-6.39
-8.17%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
40.44
-40.44
-100.00%
Secured Loans
0.00
40.44
-40.44
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.11
1.77
-1.66
-93.79%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.78
-0.78
-100.00%
Total Non-Current Liabilities
0.11
35.26
-35.15
-99.69%
Current Liabilities
Trade Payables
38.70
0.98
37.72
3,848.98%
Other Current Liabilities
0.94
0.00
0.94
0.00%
Short Term Borrowings
9.91
19.09
-9.18
-48.09%
Short Term Provisions
0.02
7.77
-7.75
-99.74%
Total Current Liabilities
49.58
27.84
21.74
78.09%
Total Liabilities
121.49
141.29
-19.80
-14.01%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
155.53
-138.68
-89.17%
Less: Accumulated Depreciation
6.37
70.65
-64.28
-90.98%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
84.88
-74.40
-87.65%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
12.84
-12.84
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.04
3.40
8,500.00%
Long Term Loans & Advances
0.75
0.00
0.75
0.00%
Other Non Current Assets
3.46
0.21
3.25
1,547.62%
Total Non-Current Assets
18.13
97.97
-79.84
-81.49%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
7.79
30.22
387.93%
Sundry Debtors
56.54
11.21
45.33
404.37%
Cash and Bank
0.16
1.21
-1.05
-86.78%
Other Current Assets
0.17
0.76
-0.59
-77.63%
Short Term Loans and Advances
8.13
22.34
-14.21
-63.61%
Total Current Assets
103.36
43.31
60.05
138.65%
Net Current Assets (Including Current Investments)
53.78
15.48
38.30
247.42%
Total Current Assets Excluding Current Investments
103.00
43.31
59.69
137.82%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
141.29
-19.80
-14.01%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
44.07
-34.16
-77.51%
Book Value per share (adjusted)
232.39
41.32
191.07
462.42%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
